EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Elective Neck Dissection in cT1‐4 N0M0 Head and Neck Spindle Cell Carcinoma

Praneet C Kaki iD, Aman M Patel, Hassaam S Choudhry, Jason A Brant, Robert M Brody, Ryan M Carey

Otolaryngology–Head and Neck Surgery · 2025-08 · 173 (2) · 433-446

DOI: 10.1002/ohn.1265 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Otolaryngology–Head and Neck Surgery, online erschienen am 21.04.2025. Verfasst von Praneet C Kaki und 5 weiteren Autor:innen. Beteiligte Einrichtung: Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania, USA. Hauptthemen laut MEDLINE: Neck Dissection, Elective Surgical Procedures, Head and Neck Neoplasms, Carcinoma. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To investigate the survival benefit of elective neck dissection (END) over neck observation in surgically resected cT1‐4 N0M0 head and neck spindle cell carcinoma (HNSpCC). Study Design Retrospective cohort study.

Setting

The 2006 to 2018 hospital‐based National Cancer Database (NCDB).

Methods

Patients with surgically resected cT1‐4 N0M0 HNSpCC were selected. Linear, binary logistic, Kaplan‐Meier, and Cox proportional hazards regression models were implemented.

Results

Of 815 patients satisfying inclusion criteria, a high proportion were male (72.4%) and white (86.0%) with disease of the larynx (43.8%) classified as high grade (87.7%) and cT1‐2 (74.8%). In total, 235 (28.8%) patients underwent END. END utilization between 2006 and 2018 increased for cT1‐2 disease (4.0% vs 30.5%, R 2 = 0.731) and for cT3‐4 disease (15.4% vs 84.6%, R 2 = 0.606). In total, 58 (24.7%) ENDs detected occult nodal metastases (ONMs). The 5‐year overall survival (OS) of patients undergoing neck observation and END was 62% and 54%, respectively ( P = .215). Among patients undergoing END, patients with ONM had worse 5‐year OS than those without ONM (38% vs 60%, P < .001). On multivariable Cox regression, END was not associated with OS (adjusted hazard ratio [aHR] 0.74, 95% CI 0.68‐1.32, P = .735); ONM (hazard ratio [HR] 2.01, 95% CI 1.29‐3.12, P = .002) was associated with worse OS.

Conclusion

END is performed in a high proportion (30%) of patients with cN0M0 HNSpCC but is not associated with higher OS. The rate of ONM approaching 25% and the association between ONM and worse OS, however, justify consideration of END in HNSpCC. Level of Evidence: 4.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neck DissectionElective Surgical ProceduresHead and Neck NeoplasmsCarcinomaHumansMaleFemaleRetrospective StudiesMiddle AgedAgedNeoplasm StagingSurvival Rate

Stichwörter der Autor:innen

National Cancer Databaseneck dissectionoccultspindle cellsurvival

Autor:innen und Institutionen

  • Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
  • Rutgers New Jersey Medical School, Newark, New Jersey, USA.
  • Department of Otorhinolaryngology-Head and Neck Surgery, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Department of Otolaryngology, Corporal Michael J. Crescenz Veterans Affairs Medical Center, Philadelphia, Pennsylvania, USA.

ORCID-Profile: Praneet C Kaki

Zitieren

APA

Kaki, P. C., Patel, A. M., Choudhry, H. S., Brant, J. A., Brody, R. M., & Carey, R. M. (2025). Elective Neck Dissection in cT1‐4 N0M0 Head and Neck Spindle Cell Carcinoma. Otolaryngology–Head and Neck Surgery, 173(2), 433-446. https://doi.org/10.1002/ohn.1265

Vancouver

Kaki PC, Patel AM, Choudhry HS, Brant JA, Brody RM, Carey RM. Elective Neck Dissection in cT1‐4 N0M0 Head and Neck Spindle Cell Carcinoma. Otolaryngology–Head and Neck Surgery. 2025;173(2):433-446. doi:10.1002/ohn.1265

BibTeX
@article{Kaki2025,
  author = {Kaki, Praneet C and Patel, Aman M and Choudhry, Hassaam S and Brant, Jason A and Brody, Robert M and Carey, Ryan M},
  title = {Elective Neck Dissection in cT1‐4 N0M0 Head and Neck Spindle Cell Carcinoma},
  journal = {Otolaryngology–Head and Neck Surgery},
  year = {2025},
  volume = {173},
  number = {2},
  pages = {433--446},
  doi = {10.1002/ohn.1265}
}
Kostenlos starten →